Pharmacovigilance is a procedure for monitoring and also managing the drug improvement, generation and marketing process. The pharmaceutic market is a exceptionally ambitious market. And it’s also a highly governed one. Drug companies are increasingly relying on technology to manage big volumes of data, in order to save time and to minimize backs on expenses. Pharmaceutical companies are growing the consumption of reliable and effective pharmacovigilance application in order to them keep up with international rules, and also, accelerate the drug production and marketing process.
All stages of the drug lifecycle may be monitored and managed proficiently with tech-savvy software program. The Clinical Trials Management System or the CTMS helps drug companies track, execute and manage medical trials efficiently. It permits integrated electronic data capture of every aspect of medical trials and streamlines all procedures, making it better to track, execute and manage the trials.
Another important aspect of the drug lifecycle is the need to track and manage negative reactions to the drug. Adverse Event Reporting System is a computerized information database that assists drug firms and regulatory authorities monitor and manage information on adverse effects of drugs. It’s an IT-based surveillance program for drugs and other biological products. It helps drug companies track adverse drug events and utilize restorative methods in order to manage drug safety dangers properly.
Pharmacovigilance signal detection also plays a primary part in pharmaceutical risk management. Each time a patient suffers from an adverse reaction to a drug, she may display some symptoms. They are the signals. The role of pharmacovigilance is to record those indicators and determine the causal reasons behind the alerts. A signal recognition application uses Information Technology to find signals helps manage product risks better.